SELLAS Life Sciences Group, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Results of operationsAug 11 →Insiders1 insider bought $100,806 in 1 open-market buy. No sales.→HoldersBlackRock 7.5%State Street 6.4%Vanguard 4.1%→Financing →PeersClosest companies: ZBIO, PYXS, ROIV→
From the filings
Figures
- Net income
- −$32.5Mlast 12 months
- Operating cash flow
- −$28.2Mlast 12 months
- Cash and equivalents
- $138.3Mat the last balance sheet
- Shares outstanding
- 201.9M shareson issue